Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.
Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.
肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。
Ohio State Outpatient Lewis Center, Lewis Center, Ohio, United States
Jameson Crane Sports Medicine Institute, Columbus, Ohio, United States
Xiangya Hospital, Changsha, China
Ehab tharwat, Damieta, New Damietta, Egypt
Campbell Clinic, Germantown, Tennessee, United States
University of California, San Diego: Dermatology Clinical Trials Unit, La Jolla, California, United States
University of Pennsylvania, Perelman Center for Advanced Medicine: Department of Dermatology, Philadelphia, Pennsylvania, United States
Children's Hospital Los Angeles: Division of Clinical Immunology & Allergy, Los Angeles, California, United States
Cairo University, Cairo, Egypt
Damascus University, Damascus, Syrian Arab Republic
Sohag University, Sohag, Egypt
Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada
Ehab tharwat, Damieta, New Damietta, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.